Primene 10% 300 mg (l-Proline LIQUID) 300 MG

PRIMENE 10% 300 MG is an intravenous solution containing L-Proline, used for various medical purposes. This liquid formulation is manufactured by Baxter Corporation in Canada.

Strength

300 MG

Pack Size

250ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PRIMENE 10% 300 MG is primarily used for intravenous administration to support certain metabolic processes. L-Proline, the active ingredient, is an amino acid that plays a role in the synthesis of collagen and the maintenance of skin and joint health. This solution may be used in clinical settings where intravenous amino acid supplementation is required.

Side Effects

When administered intravenously, PRIMENE 10% 300 MG provides essential amino acids to the body. The effects of this solution are typically observed in the context of its intended use, supporting metabolic functions and aiding in the synthesis of important biological compounds. As with any intravenous solution, individual responses may vary.

Precautions & Warnings

PRIMENE 10% 300 MG should be handled with care, ensuring proper sterile techniques are followed during administration. It is important to follow healthcare provider instructions and monitor for any adverse reactions. This solution should be stored and used according to the manufacturer's guidelines to maintain its efficacy and safety.

Avoid Interactions

PRIMENE 10% 300 MG may interact with other medications or substances when administered intravenously. It is important to inform healthcare providers about all current medications and supplements to avoid potential interactions. Specific interactions may vary depending on individual health conditions and concurrent treatments.

Frequently Asked Questions

PRIMENE 10% 300 MG is used for intravenous administration to support metabolic processes and provide essential amino acids.

PRIMENE 10% 300 MG is administered intravenously, typically in a clinical setting under the supervision of a healthcare provider.

The common effects of PRIMENE 10% 300 MG include supporting metabolic functions and aiding in the synthesis of important biological compounds.

Yes, it is important to follow sterile techniques during administration and monitor for any adverse reactions. Always follow healthcare provider instructions.

Yes, PRIMENE 10% 300 MG may interact with other medications or substances. Inform healthcare providers about all current medications to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.